New Publications

In the months of February – March 2021, we published 91 publications.

 

Make yourself familiar with our Research Publication Authorship, Affiliation and Acknowledgements Policy (NSWHP_PD_026).

Make your publication count:

All NSW Health Pathology author affiliation must include the following elements in the following order;

  1. The name of the clinical service or specialty;
  2. NSW Health Pathology’ (not New South Wales Health Pathology);
  3. Location of the service or specialty;
  4. and any additional partnership affiliations (where applicable);
  5. City and State, Country.

For example: 

1Microbiology, NSW Health Pathology, Westmead Hospital and Institute of Clinical Pathology and Medical Research, Westmead, NSW, Australia. 

 

COVID-19 RELATED PAPERS (FEB -  MAR 2021)

  1. Seroprevalence of SARS-CoV-2-specific antibodies in Sydney after the first epidemic wave of 2020. Gidding HF, Machalek DA, Hendry AJ, Quinn HE, Vette K, Beard FH, Shilling HS, Hirani R, Gosbell IB, Irving DO, Hueston L, Downes M, Carlin JB, O'Sullivan MV, Dwyer DE, Kaldor JM, Macartney K. Med J Aust. 2021 Mar;214(4):179-185. Q2 Medicine (misellaneous (SJR)).
  2. Proposed delay for safe surgery after COVID-19. Kovoor JG, Scott NA, Tivey DR, Babidge WJ, Scott DA, Beavis VS, Kok J, MacCormick AD, Padbury RTA, Hugh TJ, Hewett PJ, Collinson TG, Maddern GJ, Frydenberg M. ANZ J Surg. 2021 Mar 3. Q3 Medicine (miscellaneous (SJR)).
  3. Long-term persistence of RBD-positive memory B cells encoding neutralising antibodies in SARS-CoV-2 infection. Abayasingam A, Balachandran H, Agapiou D, Hammoud M, Rodrigo C, Keoshkerian E, Li H, Brasher NA, Christ D, Rouet R, Burnet D, Grubor-Bauk B, Rawlinson W, Turville S, Aggarwal A, Stella AO, Fichter C, Brilot F, Mina M, Post JJ, Hudson B, Gilroy N, Dwyer D, Sasson SC, Tea F, Pilli D, Kelleher A, Tedla N, Lloyd AR, Martinello M, Bull RA; COSIN study group. Cell Rep Med. 2021 Mar 14:100228.
  4. Review of studies of severe acute respiratory syndrome related coronavirus-2 pathogenesis in human organoid models. Egilmezer E, Rawlinson WD. Rev Med Virol. 2021 Mar 25. Q1 Infectious Diseases (SJR).
  5. An evaluation of 4 commercial assays for the detection of SARS-CoV-2 antibodies in a predominantly mildly symptomatic low prevalence Australian population. Wehrhahn MC, Brown SJ, Newcombe JP, Chong S, Evans J, Figtree M, Hainke L, Hueston L, Khan S, Marland E, O'Sullivan MVN, Powell H, Roy J, Waring L, Yu M, Robson J. J Clin Virol. 2021 Mar 17; 138:104797. Q1 Infectious Diseases (SJR).
  6. Guidance for the design and reporting of studies evaluating the clinical performance of tests for present or past SARS-CoV-2 infection. Doust JA, Bell KJL, Leeflang MMG, Dinnes J, Lord SJ, Mallett S, van de Wijgert JHHM, Sandberg S, Adeli K, Deeks JJ, Bossuyt PM, Horvath AR. BMJ. 2021 Mar 29; 372: n568. Q1 Medicine (miscellaneous (SJR)).
  7. Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing. Kim KW, Deveson IW, Pang CNI, Yeang M, Naing Z, Adikari T, Hammond JM, Stevanovski I, Beukers AG, Verich A, Yin S, McFarlane D, Wilkins MR, Stelzer-Braid S, Bull RA, Craig ME, van Hal SJ, Rawlinson WD. Sci Rep. 2021 Feb 16;11(1):3934. Q1 Multidisciplinary (SJR).
  8. SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays. Walker GJ, Naing Z, Ospina Stella A, Yeang M, Caguicla J, Ramachandran V, Isaacs SR, Agapiou D, Bull RA, Stelzer-Braid S, Daly J, Gosbell IB, Hoad VC, Irving DO, Pink JM, Turville S, Kelleher AD, Rawlinson WD. Viruses. 2021 Feb 4;13(2):247. Q1 Infectious Diseases (SJR).
  9. Seroprevalence of SARS-CoV-2-specific antibodies in Sydney after the first epidemic wave of 2020. Gidding HF, Machalek DA, Hendry AJ, Quinn HE, Vette K, Beard FH, Shilling HS, Hirani R, Gosbell IB, Irving DO, Hueston L, Downes M, Carlin JB, O'Sullivan MV, Dwyer DE, Kaldor JM, Macartney K. Med J Aust. 2021 Mar;214(4):179-185. Q2 Medicine (miscellaneous (SJR)).
  10. Lessons from a successful public health response to COVID-19 in a New South Wales residential aged care facility, 2020. Zheng A, Govindasamy LS, Thomas J, Branley J, Craig AT, Douglas M. Aust N Z J Public Health. 2021 Feb;45(1):13-16. Q1 Public Health, Environmental and Occupational Health (SJR).
  11. Laboratory diagnosis of COVID-19 in China: A review of challenging cases and analysis. Jing R, Kudinha T, Zhou ML, Xiao M, Wang H, Yang WH, Xu YC, Hsueh PR. J Microbiol Immunol Infect. 2021 Feb;54(1):17-26. Q1 Medicine (miscellaneous (SJR)).
  12. Setting minimum clinical performance specifications for tests based on disease prevalence and minimum acceptable positive and negative predictive values: Practical considerations applied to COVID-19 testing. Loh TP, Lord SJ, Bell K, Bohn MK, Lim CY, Markus C, Fares Taie H, Adeli K, Lippi G, Sandberg S, Horvath A. Clin Biochem. 2021 Feb; 88:18-22. Q2 Clinical Biochemistry (SJR).

 

MARCH 2021

  1. The NSW Pathology Atlas of Variation: Part I-Identifying Emergency Departments With Outlying Laboratory Test-Ordering Practices. Wabe N, Thomas J, Scowen C, Eigenstetter A, Lindeman R, Georgiou A. Ann Emerg Med. 2021 Mar 24: S0196-0644(21)00061-5. Q1 Emergency Medicine (SJR).
  2. Management of a rare cause of upper gastrointestinal bleed: the duodenal gangliocytic paraganglioma. Kotecha K, Paik J, Gill AJ, Samra JS, Mittal A. ANZ J Surg. 2021 Mar 25. Q3 Medicine (miscellaneous (SJR)).
  3. Value of routine whole genome sequencing for Mycobacterium tuberculosis drug resistance detection. Lam C, Martinez E, Crighton T, Furlong C, Donnan E, Marais BJ, Sintchenko V. Int J Infect Dis. 2021 Mar 19: S1201-9712(21)00251-4. Q1 Infectious Diseases (SJR).
  4. Therapeutic Drug Monitoring in Non-Tuberculosis Mycobacteria Infections. Alffenaar JW, Märtson AG, Heysell SK, Cho JG, Patanwala A, Burch G, Kim HY, Sturkenboom MGG, Byrne A, Marriott D, Sandaradura I, Tiberi S, Sintchencko V, Srivastava S, Peloquin CA. Clin Pharmacokinet. 2021 Mar 10. Q1 Pharmacology (SJR).
  5. Interobserver concordance in visual assessment of Ki67 immunohistochemistry in surgical excision specimens from patients with lymph node-negative breast cancer. Thomas S, Kabir M, Butcher BE, Chou S, Mahajan H, Farshid G, Balleine R, Pathmanathan N. Breast Cancer Res Treat. 2021 Mar 22. Q1 Cancer Research (SJR).
  6. Prophylactic antigen-specific T-cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplant. Gottlieb DJ, Clancy LE, Withers B, McGuire HM, Luciani F, Singh M, Hughes B, Gloss B, Kliman D, Ma CKK, Panicker S, Bishop D, Dubosq MC, Li Z, Avdic S, Micklethwaite K, Blyth E. Clin Transl Immunology. 2021 Mar 15;10(3): e1249. Q1 Immunology (SJR).
  7. Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma. Rawson RV, Adhikari C, Bierman C, Lo S, Shklovskaya E, Rozeman EA, Menzies AM, van Akkooi ACJ, Shannon KF, Gonzalez M M, Guminski AD, Tetzlaff MT, Stretch JR, Eriksson H, van Thienen JV, Wouters MW, Haanen JBAG, Klop WMC, Zuur CL, van Houdt WJ, Nieweg OE, Ch'ng S, Rizos H, Saw RPM, Spillane AJ, Wilmott JS, Blank CU, Long GV, van de Wiel BA, Scolyer RA. Ann Oncol. 2021 Mar 17: S0923-7534(21)00884-X. Q1 Medicine (miscellaneous (SJR)).
  8. Cost of whole genome sequencing for non-typhoidal Salmonella enterica. Ford L, Glass K, Williamson DA, Sintchenko V, Robson JMB, Lancsar E, Stafford R, Kirk MD. PLoS One. 2021 Mar 19;16(3): e0248561. Q1 Multidisciplinary (SJR).
  9. Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment. Hvas AM, Favaloro EJ, Hellfritzsch M. Expert Rev Hematol. 2021 Mar 30:1-12. Q2 Hematology (SJR).
  10. Correction to: Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia. Trpkov K, Williamson SR, Gill AJ, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Hes O. Mod Pathol. 2021 Mar 16. Q1 Pathology and Forensic Medicine (SJR).
  11. Medical treatment of polymeric cerebral granulomatous reactions following endovascular procedures. Boyle T, Fernando SL, Steinfort B, Li J, Krause M, Harrington T, Assaad N, Faulder K. J Neurointerv Surg. 2021 Mar 15: neurintsurg-2020-016806. Q1 Medicine (miscellaneous (SJR)).
  12. Relationship between PD-L1 expression and outcome in EGFR-mutant lung cancer patients treated with EGFR tyrosine kinase inhibitors. Liu J, Itchins M, Nagrial A, Cooper WA, De Silva M, Barnet M, Varikatt W, Sivasubramaniam V, Davis A, Gill AJ, Blinman P, Lee K, Hui R, Gao B, Pavlakis N, Clarke S, Lee J, Boyer M, Kao S. Lung Cancer. 2021 Mar 9; 155:28-33. Q1 Cancer Research (SJR).
  13. In vitro and in vivo Effect of Antimicrobial Agent Combinations Against Carbapenem-Resistant Klebsiella pneumoniae with Different Resistance Mechanisms in China. Liu E, Jia P, Li X, Zhou M, Kudinha T, Wu C, Xu Y, Yang Q. Infect Drug Resist. 2021 Mar 5; 14:917-928. Q1 Pharmacology (SJR).
  14. Receptors in host pathogen interactions between human cytomegalovirus and the placenta during congenital infection. Singh K, Hamilton ST, Shand AW, Hannan NJ, Rawlinson WD. Rev Med Virol. 2021 Mar 11. Q1 Infectious Diseases (SJR).
  15. Pneumocystis jirovecii Disease: Basis for the Revised EORTC/MSGERC Invasive Fungal Disease Definitions in Individuals Without Human Immunodeficiency Virus. Lagrou K, Chen S, Masur H, Viscoli C, Decker CF, Pagano L, Groll AH. Clin Infect Dis. 2021 Mar 12;72(Supplement_2): S114-S120. Q1 Infectious Diseases (SJR).
  16. The Evidence Supporting the Revised EORTC/MSGERC Definitions for Invasive Fungal Infections. Pappas PG, Chen SC, Donnelly JP. Clin Infect Dis. 2021 Mar 12;72(Supplement_2): S77-S78. Q1 Infectious Diseases (SJR).
  17. PD-L1 Is Preferentially Expressed in PIT-1 Positive Pituitary Neuroendocrine Tumours. Turchini J, Sioson L, Clarkson A, Sheen A, Gill AJ. Endocr Pathol. 2021 Mar 11. Q1 Medicine (miscellaneous (SJR)).
  18. TB genomic surveillance and data sharing in recognising contamination events. Kizny Gordon A, Tong SYC, Martinez E, Crighton T, Denholm JT, Sintchenko V. Int J Tuberc Lung Dis. 2021 Mar 1;25(3):241-243. Q1 Infectious Diseases (SJR).
  19. γδ T cells in Merkel cell carcinomas have a proinflammatory profile prognostic of patient survival. Gherardin NA, Waldeck K, Caneborg A, Martelotto LG,Balachander S, Zethoven M, Petrone PM, Pattison A, Wilmott JS, Quiñones-Parra SM, Rossello F, Posner A, Wong A, Weppler AM, Shannon KF, Hong A, Ferguson PM, Jakrot V, Raleigh J, Hatzimihalis A, Neeson PJ, Deleso P, Johnston M, Chua M, Becker JC, Sandhu S, McArthur GA, Gill AJ, Scolyer RA, Hicks RJ, Godfrey DI, Tothill RW. Cancer Immunol Res. 2021 Mar 5: canimm.0817.2020. Q1 Cancer Research (SJR).
  20. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Trpkov K, Hes O, Williamson SR, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Gill AJ. Mod Pathol. 2021 Mar 4. Q1 Pathology and Forensic Medicine (SJR).
  21. Associations of serum short-chain fatty acids with circulating immune cells and serum biomarkers in patients with multiple sclerosis. Trend S, Leffler J, Jones AP, Cha L, Gorman S, Brown DA, Breit SN, Kermode AG, French MA, Ward NC, Hart PH. Sci Rep. 2021 Mar 4;11(1):5244. Q1 Multidisciplinary (SJR).
  22. The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC. Mino-Kenudson M, Le Stang N, Daigneault JB, Nicholson AG, Cooper WA, Roden AC, Moreira AL, Thunnissen E, Papotti M, Pelosi G, Motoi N, Poleri C, Brambilla E, Redman M, Jain D, Dacic S, Yatabe Y, Tsao MS, Lopez-Rios F, Botling J, Chen G, Chou TY, Hirsch FR, Beasley MB, Borczuk A, Bubendorf L, Chung JH, Hwang D, Lin D, Longshore J, Noguchi M, Rekhtman N, Sholl L, Travis W, Yoshida A, Wynes MW, Wistuba II, Kerr KM, Lantuejoul S. J Thorac Oncol. 2021 Apr;16(4):686-696. Q1 Medicine (miscellaneous (SJR)).
  23. Granulomatous skin lesions of common variable immunodeficiency treated with sirolimus. Lee AY, Huynh N, Lin MW. Australas J Dermatol. 2021 Mar 4. Q2 Dermatology (SJR).
  24. Machine learning and coagulation testing: the next big thing in hemostasis investigations? Favaloro EJ, Negrini D. Clin Chem Lab Med. 2021 Mar 2. Q1 Biochemistry (medical (SJR)).
  25. Predicting sentinel node positivity in melanoma patients: external validation of a risk-prediction calculator (the MIA nomogram) using a large European population-based patient cohort. El Sharouni MA, Varey AHR, Witkamp AJ, Ahmed T, Sigurdsson V, van Diest PJ, Scolyer RA, Thompson JF, Lo SN, van Gils CH. Br J Dermatol. 2021 Mar 3. Q1 Dermatology (SJR).
  26. Use of multiparametric magnetic resonance imaging (mpMRI) in active surveillance for low-risk prostate cancer: a scoping review on the benefits and harm of mpMRI in different biopsy scenarios. Chiam K, Carle C, Hughes S, Kench JG, Woo HH, Lord S, Smith DP. Prostate Cancer Prostatic Dis. 2021 Mar 2. Q1 Cancer Research (SJR).
  27. Levels of haemolysis have no effect on femoral vein post-mortem tryptase levels. Garland J, Ondruschka B, Broi UD, Palmiere C, Glenn C, Morrow P, Kesha K, Stables S, Tse R. Med Sci Law. 2021 Mar 2:25802421998851. Q2 Issues, Ethics and Legal Aspects (SJR).
  28. Diagnostic Yield of Whole Genome Sequencing After Nondiagnostic Exome Sequencing or Gene Panel in Developmental and Epileptic Encephalopathies. Palmer EE, Sachdev R, Macintosh R, Melo US, Mundlos S, Righetti S, Kandula T, Minoche AE, Puttick C, Gayevskiy V, Hesson L, Idrisoglu S, Shoubridge C, Thai MHN, Davis RL, Drew AP, Sampaio H, Andrews PI, Lawson J, Cardamone M, Mowat D, Colley A, Kummerfeld S, Dinger ME, Cowley MJ, Roscioli T, Bye A, Kirk E. Neurology. 2021 Mar 30;96(13): e1770-e1782. Q1 Neurology (clinical (SJR)).
  29. Multiple Endocrine Tumors Associated with Germline MAX Mutations: Multiple Endocrine Neoplasia Type 5? Seabrook AJ, Harris JE, Velosa SB, Kim E, McInerney-Leo AM, Dwight T, Hockings JI, Hockings NG, Kirk J, Leo PJ, Love AJ, Luxford C, Marshall M, Mete O, Pennisi DJ, Brown MA, Gill AJ, Hockings GI, Clifton-Bligh RJ, Duncan EL. J Clin Endocrinol Metab. 2021 Mar 25;106(4):1163-1182. Q1 Biochemistry (SJR).
  30. The Insect-Specific Parramatta River Virus Is Vertically Transmitted by Aedes vigilax Mosquitoes and Suppresses Replication of Pathogenic Flaviviruses In Vitro. McLean BJ, Hall-Mendelin S, Webb CE, Bielefeldt-Ohmann H, Ritchie SA, Hobson-Peters J, Hall RA, van den Hurk AF. Vector Borne Zoonotic Dis. 2021 Mar;21(3):208-215. Q2 Infectious Diseases (SJR).
  31. A 6-step rapid desensitization protocol to hydroxychloroquine. Sutton KM, Fernando SL. Ann Allergy Asthma Immunol. 2021 Mar;126(3):292-293. Q2 Immunology (SJR).
  32. Sentinel node biopsy in patients with melanoma improves the accuracy of staging when added to clinicopathological features of the primary tumor. El Sharouni MA, Stodell MD, Ahmed T, Suijkerbuijk KPM, Cust AE, Witkamp AJ, Sigurdsson V, van Diest PJ, Scolyer RA, Thompson JF, van Gils CH, Lo SN. Ann Oncol. 2021 Mar;32(3):375-383. Q1 Medicine (miscellaneous (SJR)).
  33. No Evidence That Salt Water Ingestion Kills Adult Mosquitoes (Diptera: Culicidae). Yee DA, Dean C, Webb C, Henke JA, Perezchica-Harvey G, White GS, Faraji A, Macaluso JD, Christofferson R. J Med Entomol. 2021 Mar 12;58(2):767-772. Q1 Insect Science (SJR).
  34. Chlamydia pecorum-Induced Arthritis in Experimentally and Naturally Infected Sheep. Ostfeld N, Islam MM, Jelocnik M, Hilbe M, Sydler T, Hartnack S, Jacobson C, Clune T, Marsh I, Sales N, Polkinghorne A, Borel N. Vet Pathol. 2021 Mar;58(2):346-360. Q1 Veterinary (miscellaneous (SJR)).
  35. Risk factors for candidaemia: A prospective multi-centre case-control study. Keighley CL, Pope A, Marriott DJE, Chapman B, Bak N, Daveson K, Hajkowicz K, Halliday C, Kennedy K, Kidd S, Sorrell TC, Underwood N, van Hal S, Slavin MA, Chen SC. Mycoses. 2021 Mar;64(3):257-263. Q1 Dermatology (SJR).
  36. A Critical Assessment of Postneoadjuvant Therapy Pancreatic Cancer Regression Grading Schemes With a Proposal for a Novel Approach. Chou A, Ahadi M, Arena J, Sioson L, Sheen A, Fuchs TL, Pavlakis N, Clarke S, Kneebone A, Hruby G, Sahni S, Mittal A, Samra J, Gill AJ. Am J Surg Pathol. 2021 Mar 1;45(3):394-404. Q1 Anatomy (SJR).
  37. SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. Horton RK, Ahadi M, Gill AJ, Said S, Chen ZE, Bakhshwin A, Nichols M, Goldblum JR, Graham RP. Am J Surg Pathol. 2021 Mar 1;45(3):414-420. Q1 Anatomy (SJR).
  38. Cepheid Xpert® Flu/RSV and Seegene Allplex RP1 show high diagnostic agreement for the detection of influenza A/B and respiratory syncytial viruses in clinical practice. Wabe N, Lindeman R, Post JJ, Rawlinson W, Miao M, Westbrook JI, Georgiou A. Influenza Other Respir Viruses. 2021 Mar;15(2):245-253. Q1 Epidemiology (SJR).

FEBRUARY 2021

  1. Monocyte phenotype as a predictive marker for wound healing in diabetes-related foot ulcers. Min D, Nube V, Tao A, Yuan X, Williams PF, Brooks BA, Wong J, Twigg SM, McLennan SV. J Diabetes Complications. 2021 Feb 16:107889. Q1 Internal Medicine (SJR).
  2. NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population. Ramanayake N, Vargas AC, Talbot J, Bonar F, Wong DD, Wong D, Mahar A, Karim R, Luk PP, Selinger C, Sioson L, Gill AJ, Maclean F. Pathology. 2021 Feb 24: S0031-3025(21)00050-7. Q1 Pathology and Forensic Medicine (SJR).
  3. ClinSV: clinical grade structural and copy number variant detection from whole genome sequencing data. Minoche AE, Lundie B, Peters GB, Ohnesorg T, Pinese M, Thomas DM, Zankl A, Roscioli T, Schonrock N, Kummerfeld S, Burnett L, Dinger ME, Cowley MJ. Genome Med. 2021 Feb 25;13(1):32. Q1 Genetics (SJR).
  4. Is gentamicin a viable therapeutic option for treating resistant Neisseria gonorrhoeae in New South Wales? Armstrong BH, Limnios A, Lewis DA, Hogan T, Kundu R, Ray S, Shoushtari M, El Nasser J, Driscoll T, Lahra MM. Commun Dis Intell (2018). 2021 Feb 26;45.
  5. Estimating the potential impact of interventions to reduce over-calling and under-calling of melanoma. Gibson M, Scolyer RA, Soyer HP, Ferguson P, McGeechan K, Irwig L, Bell K. J Eur Acad Dermatol Venereol. 2021 Feb 25. Q1 Dermatology (SJR).
  6. Effect of age and gender in non-smokers with oral squamous cell carcinoma: Multi-institutional study. Oh LJ, Asher R, Veness M, Smee R, Goldstein D, Gopalakrishna Iyer N, Balasubramanian D, Low TH, Palme CE, Gupta R, Clark J. Oral Oncol. 2021 Feb 19; 116:105210. Q1 Cancer Research (SJR).
  7. A case report of successful transition from argatroban to warfarin using DOAC-stop in heparin induced thrombocytopenia (HIT). Makhija K, Chapman K, Prasad R. Pathology. 2021 Feb 17: S0031-3025(21)00022-2. Q1 Pathology and Forensic Medicine (SJR).
  8. Predisposing factors, microbiological features and outcomes of patients with clinical presumed concomitant microbial and herpes simplex keratitis. Cabrera-Aguas M, Khoo P, George CRR, Lahra MM, Watson SL. Eye (Lond). 2021 Feb 19. Q1 Arts and Humanities (SJR).
  9. Reply to Dr Hawkins regarding comparability of results for monitoring. Sikaris K, Koerbin G, Jones G, Flatman R. Clin Chem Lab Med. 2021 Feb 22. Q1 Bichemistry (medical (SJR)).
  10. Tumour gene expression signature in primary melanoma predicts long-term outcomes. Garg M, Couturier DL, Nsengimana J, Fonseca NA, Wongchenko M, Yan Y, Lauss M, Jönsson GB, Newton-Bishop J, Parkinson C, Middleton MR, Bishop DT, McDonald S, Stefanos N, Tadross J, Vergara IA, Lo S, Newell F, Wilmott JS, Thompson JF, Long GV, Scolyer RA, Corrie P, Adams DJ, Brazma A, Rabbie R. Nat Commun. 2021 Feb 18;12(1):1137. Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous (SJR)).
  11. Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas. El Sharouni MA, Ahmed T, Varey AHR, Elias SG, Witkamp AJ, Sigurdsson V, Suijkerbuijk KPM, van Diest PJ, Scolyer RA, van Gils CH, Thompson JF, Blokx WAM, Lo SN. J Clin Oncol. 2021 Feb 18: JCO2002446. Q1 Cancer Research (SJR).
  12. Predicting distant metastatic disease in differentiated thyroid cancer: a matched case-control study. Jaffar S, Jayasekara J, Aniss AM, Tsang VHM, Learoyd DL, Clifton-Bligh R, Gill AJ, Glover AR, Sidhu SB, Robinson B, Sywak M. ANZ J Surg. 2021 Feb 16. Q3 Medicine (miscellaneous (SJR)).
  13. G9a inhibition enhances checkpoint inhibitor blockade response in melanoma. Kelly G, Al-Ejeh F, McCuaig RD, Casciello F, Kamal N, Ferguson B, Pritchard AL, Ali S, Silva I, Wilmott JS, Long GV, Scolyer RA, Rao S, Hayward NK, Gannon F, Lee JS. Clin Cancer Res. 2021 Feb 15: clincanres.3463.2020. Q1 Cancer Research (SJR).
  14. Efficacy of aerosolized hydrogen peroxide (Deprox) cleaning compared to physical cleaning in a Burns Unit. McKew G, Phan T, Cai T, Taggart S, Cheong E, Gottlieb T. Infect Dis Health. 2021 Feb 10: S2468-0451(21)00003-1. Q2 Nursing (miscellaneous (SJR)).
  15. Diagnostic Yield of Whole Genome Sequencing After Non-diagnostic Exome Sequencing or Gene Panel in Developmental and Epileptic Encephalopathies. Palmer EE, Sachdev R, Macintosh R, Genetic Counselling GD, Melo US, Mundlos S, Righetti S, Kandula T, Minoche AE, Puttick C, Gayevskiy V, Hesson L, Idrisoglu S, Shoubridge C, Thai MHN, Davis RL, Drew AP, Sampaio H, Andrews PI, Lawson J, Cardamone M, Mowat D, Colley A, Kummerfeld S, Dinger ME, Cowley MJ, Roscioli T, Bye A, Kirk E. Neurology. 2021 Feb 10:10.1212/WNL.0000000000011655. Q1 Neurology (clinical (SJR)).
  16. Paediatric genomic testing: Navigating medicare rebatable genomic testing. Sachdev R, Field M, Baynam GS, Beilby J, Berarducci M, Berman Y, Boughtwood T, Cusack MB, Fitzgerald V, Fletcher J, Freckmann ML, Grainger N, Kirk E, Lundie B, Lunke S, McGregor L, Mowat D, Parasivam G, Tyrell V, Wallis M, White SM, S L Ma A. J Paediatr Child Health. 2021 Feb 10. Q2 Pediatrics, Perinatology and Child Health (SJR).
  17. Targeting the Microbiome to Overcome Resistance. Simpson RC, Shanahan E, Scolyer RA, Long GV. Cancer Cell. 2021 Feb 8;39(2):151-153. Q1 Cancer Research (SJR).
  18. Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma. Rozeman EA, Hoefsmit EP, Reijers ILM, Saw RPM, Versluis JM, Krijgsman O, Dimitriadis P, Sikorska K, van de Wiel BA, Eriksson H, Gonzalez M, Torres Acosta A, Grijpink-Ongering LG, Shannon K, Haanen JBAG, Stretch J, Ch'ng S, Nieweg OE, Mallo HA, Adriaansz S, Kerkhoven RM, Cornelissen S, Broeks A, Klop WMC, Zuur CL, van Houdt WJ, Peeper DS, Spillane AJ, van Akkooi ACJ, Scolyer RA, Schumacher TNM, Menzies AM, Long GV, Blank CU. Nat Med. 2021 Feb;27(2):256-263. Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous (SJR)).
  19. Up-regulation of DNA Damage Response Signaling in Autosomal Dominant Polycystic Kidney Disease. Zhang JQJ, Saravanabavan S, Chandra AN, Munt A, Wong ATY, Harris PC, Harris DCH, McKenzie P, Wang Y, Rangan GK. Am J Pathol. 2021 Feb 4: S0002-9440(21)00042-0. Q1 Pathology and Forensic Medicine (SJR).
  20. Young age is not a predictor of disease specific survival in oral cancer: A multi-institutional study. Oh LJ, Satgunaseelan L, Asher R, Veness M, Smee R, Goldstein D, Gopalakrishna Iyer N, Balasubramanian D, Low H, Palme CE, Gupta R, Clark JR. Oral Oncol. 2021 Feb 3; 115:105162. Q1 Cancer Research (SJR).
  21. Desmoplastic Melanoma: A review of its pathology and clinical behaviour, and of management recommendations in published guidelines. Hughes TM, Williams GJ, Gyorki DE, Kelly JW, Stretch JR, Varey AHR, Hong AM, Scolyer RA, Thompson JF. J Eur Acad Dermatol Venereol. 2021 Feb 5. Q1 Dermatology (SJR).
  22. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Trpkov K, Williamson SR, Gill AJ, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Hes O. Mod Pathol. 2021 Feb 1. Q1 Pathology and Forensic Medicine (SJR).
  23. Molecular Features of Lymph Node Metastasis in T1/2 Colorectal Cancer from Formalin-Fixed Paraffin-Embedded Archival Specimens. Steffen P, Li J, Chandra J, Ahadi MS, Gill AJ, Engel AF, Molloy MP. J Proteome Res. 2021 Feb 5;20(2):1304-1312. Q1 Biochemistry (SJR).
  24. Bacterial association observations in Lucilia sericata and Lucilia cuprina organs through 16S rRNA gene sequencing. Gasz NE, Geary MJ, Doggett SL, Harvey ML. Appl Microbiol Biotechnol. 2021 Feb;105(3):1091-1106. Q1 Applied Microbiology and Biotechnology (SJR).
  25. Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation. Paver EC, Cooper WA, Colebatch AJ, Ferguson PM, Hill SK, Lum T, Shin JS, O'Toole S, Anderson L, Scolyer RA, Gupta R. Pathology. 2021 Feb;53(2):141-156. Q1 Pathology and Forensic Medicine (SJR).
  26. Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma. El Sharouni MA, Aivazian K, Witkamp AJ, Sigurdsson V, van Gils CH, Scolyer RA, Thompson JF, van Diest PJ, Lo SN. JAMA Dermatol. 2021 Feb 1;157(2):166-173. Q1 Dermatology (SJR).
  27. The Immune Dysregulation of Common Variable Immunodeficiency Disorders. Fernando SL, Jang HS, Li J. Immunol Lett. 2021 Feb;230:21-26. Q2 Immunology (SJR).
  28. The GDF15-GFRAL Pathway in Health and Metabolic Disease: Friend or Foe? Breit SN, Brown DA, Tsai VW. Annu Rev Physiol. 2021 Feb 10; 83:127-151. Q1 Physiology (SJR).
  29. A multicenter laboratory assessment of a new automated chemiluminescent assay for ADAMTS13 activity. Favaloro EJ, Mohammed S, Chapman K, Swanepoel P, Zebeljan D, Sefhore O, Malan E, Clifford J, Yuen A, Donikian D, Kondo M, Duncan E, Abraham S, Beggs J, Chatrapati R, Perel J, Coleman R, Klose N, Hsu D, Motum P, Tan CW, Brighton T, Pasalic L. J Thromb Haemost. 2021 Feb;19(2):417-428. Q1 Hematology (SJR).
  30. Prognostic value of the 8th edition American Joint Commission Cancer nodal staging system for patients with head and neck cutaneous squamous cell carcinoma: A multi-institutional study. Luk PP, Ebrahimi A, Veness MJ, McDowell L, Magarey M, Gao K, Palme CE, Clark JR, Gupta R. Head Neck. 2021 Feb;43(2):558-567. Q1 Otorhinolaryngology (SJR).
  31. GLI activated epithelioid cell tumour: report of a case and proposed new terminology. Aivazian K, Mahar A, Jackett LA, Kimble RM, Scolyer RA. Pathology. 2021 Feb;53(2):267-270. Q1 Pathology and Forensic Medicine (SJR).
  32. A multicentre assessment of contemporary laboratory assays for heparin induced thrombocytopenia. Favaloro EJ, Mohammed S, Donikian D, Kondo M, Duncan E, Yacoub O, Zebeljan D, Ng S, Malan E, Yuen A, Beggs J, Moosavi S, Coleman R, Klose N, Chapman K, Cavanaugh L, Pasalic L, Motum P, Tan CW, Brighton T. Pathology. 2021 Feb;53(2):247-256. Q1 Pathology and Forensic Medicine (SJR).
  33. Plasma vs serum as test sample for the chemiluminescent AcuStar HemosIL HIT-IgG(PF4-H) assay. Favaloro EJ, Mohammed S. Int J Lab Hematol. 2021 Feb;43(1): e41-e44. Q2 Biochemistry (medical (SJR)).
  34. Rapid detection of enteric pathogens in a medical assistance team by real-time multiplex PCR. Branley J, Trewin A, Gray TJ, Polkinghorne A. Pathology. 2021 Feb;53(2):290-292. Q1 Pathology and Forensic Medicine (SJR).
  35. Standardization of Prothrombin Time/International Normalized Ratio (PT/INR). Dorgalaleh A, Favaloro EJ, Bahraini M, Rad F. Int J Lab Hematol. 2021 Feb;43(1):21-28. Q2 Biochemistry (medical (SJR)).
  36. Periodontal Disease and Venous Thromboembolism. Lippi G, Nocini R, Favaloro EJ. Semin Thromb Hemost. 2021 Feb;47(1):110-111. Q1 Cardiology and Cardiovascular Medicine (SJR).
  37. In-hospital acute stroke workflow in acute stroke - Systems-based approaches. Santana Baskar P, Cordato D, Wardman D, Bhaskar S. Acta Neurol Scand. 2021 Feb;143(2):111-120. Q1 Medicine (miscellaneous (SJR).
  38. Cerebral collaterals in acute ischaemia: Implications for acute ischaemic stroke patients receiving reperfusion therapy. Ravindran AV, Killingsworth MC, Bhaskar S. Eur J Neurosci. 2021 Feb;53(4):1238-1261. Q2 Neuroscience (miscellaneous (SJR)). Q1 Cardiology and Cardiovascular Medicine (SJR).
  39. The potential for overdiagnosis and underdiagnosis because of blood pressure variability: a comparison of the 2017 ACC/AHA, 2018 ESC/ESH and 2019 NICE hypertension guidelines. Bell K, Doust J, McGeechan K, Horvath AR, Barratt A, Hayen A, Semsarian C, Irwig L. J Hypertens. 2021 Feb 1;39(2):236-242. Q1 Cardiology and Cardiovascular Medicine (SJR).
  40. Real-world programmed death-ligand 1 prevalence rates in non-small cell lung cancer: correlation with clinicopathological features and tumour mutation status. Holmes M, Mahar A, Lum T, Kao S, Cooper WA. J Clin Pathol. 2021 Feb;74(2):123-128. Q1 Medicine (miscellaneous (SJR)).
  41. Interlaboratory evaluation of Mucorales PCR assays for testing serum specimens: A study by the fungal PCR Initiative and the Modimucor study group. Rocchi S, Scherer E, Mengoli C, Alanio A, Botterel F, Bougnoux ME, Bretagne S, Cogliati M, Cornu M, Dalle F, Damiani C, Denis J, Fuchs S, Gits-Muselli M, Hagen F, Halliday C, Hare R, Iriart X, Klaassen C, Lackner M, Lengerova M, Letscher-Bru V, Morio F, Nourrisson C, Posch W, Sendid B, Springer J, Willinger B, White PL, Barnes RA, Cruciani M, Donnelly JP, Loeffler J, Millon L. Med Mycol. 2021 Feb 4;59(2):126-138. Q1 Medicine (miscellaneous (SJR)).